📰 Compared With News
Page 13 - Compared With News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Compared With. Real-time updates on events, politics, business and more.
June 1, 2021
Die Swiss Alps Classics in Andermatt feiern Jubiläum. Mit Unternehmer Samih Sawiris hat das Klassikfestival (fast) nichts zu tun.
June 1, 2021
Forschende untersuchen Methoden, um FFP2-Masken zu Hause aufzubereiten. Eine Variante funktioniert besonders gut.
May 30, 2021
Landesweit sind Brasilianer wieder gegen den laxen Umgang ihres Präsidenten mit der Pandemie auf die Straße gegangen. Sie forderten Bolsonaros Amtsenthebung und verglichen dessen Corona-Verharmlosung mit Völkermord.
May 25, 2021
AUGSBURG (dpa-AFX) - "Augsburger Allgemeine" zur Antisemitismus-Debatte: "Wer "Nie wieder!" sagt, muss daraus den Auftrag ableiten, dass diese Menschen in Deutschland stets sicher sind. Wir kommen diesem
May 5, 2021
Bald geht die Testphase des EU-weiten digitalen Impfpasses los. Einzelne Länder sind längst einen Schritt weiter. Ein Überblick.
April 21, 2021
NET INTEREST INCOME Net interest income increased by $2.1 million to $261.3 million for the first quarter of 2021 compared to $259.2 million for the fourth quarter of 2020 due mainly to higher income on investment securities and lower interest expense, partially offset by lower income on loans and leases and the negative impact on net interest income due to the change in the earning assets mix. The tax equivalent yield on average loans and leases was 5.20% for the first quarter of 2021 compared...
January 26, 2021
(2) KEYTRUDA Is First Checkpoint Inhibitor Approved in Europe to Treat MSI-H or dMMR Colorectal Cancer European Approval Based on Results From KEYNOTE-177 Trial Demonstrating KEYTRUDA Significantly Reduced Risk of Disease Progression or Death by 40% Compared With Chemotherapy Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the European Commission has approved KEYTRUDA, Mercks anti-PD-1 therapy, as a monotherapy for the first-line treatment of adult pa...